Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome

Kahraman S., Altinova A., Yalcin M. M., Gulbahar Ö., Arslan B., Akturk M. Y., ...Daha Fazla

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, cilt.41, sa.9, ss.1069-1074, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 9
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s40618-018-0831-2
  • Dergi Adı: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1069-1074
  • Anahtar Kelimeler: Betatrophin, Body mass index, Fibroblast growth factor-21, Luteinizing hormone, Polycystic ovary syndrome, INSULIN-RESISTANCE, CIRCULATING LEVELS, LIPID-METABOLISM, GLUCOSE, DYSLIPIDEMIA, CONSENSUS, OBESITY, CHREBP
  • Gazi Üniversitesi Adresli: Evet

Özet

Purpose Betatrophin and fibroblast growth factor-21 (FGF-21), which are recently discovered members of hepatokine/adipokine family, have been proposed to be associated with some metabolic disorders in which insulin resistance plays a major role.